Docj,

Thank you for taking the time to reach out to Dr. BP. Confirmation that his paper will be out soon is outstanding.

I am not discounting the PDUFA date announcement or uplisting to support lagging share price, but validation of Dr. BP's findings in a peer reviewed journal, IMO is the next best alternative to positive results from the placebo controlled trials.

This is the most encouraging news I have seen here in a bit.

The science and progress to widespread clinical utilization of Leronlimab are paramount.

Everything else is secondary.

Thanks and have a great weekend.